A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Deerfield Sues Alcon over Latest Moves to Prevent Aurion IPO
Author: Joan McKenna
Deerfield Management has filed a lawsuit against an Alcon subsidiary, seeking to prevent Alcon from interfering with Aurion Biotech’s ability to launch an initial public offering. The lawsuit, filed Feb. 24 in the Court of Chancery of the State of Delaware, claims Alcon has been trying to take over Aurion, developer of a corneal cell therapy, at a highly discounted valuation. Deerfield, of New York, and Alcon, a Swiss company with US headquarters in Texas, both invested in Aurion as part of a...
Purchasing one of the following products will open up access to this article's content, which is also available in each comprehensive report/subscription.